These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20102920)

  • 21. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.
    Moss AJ; Shimizu W; Wilde AA; Towbin JA; Zareba W; Robinson JL; Qi M; Vincent GM; Ackerman MJ; Kaufman ES; Hofman N; Seth R; Kamakura S; Miyamoto Y; Goldenberg I; Andrews ML; McNitt S
    Circulation; 2007 May; 115(19):2481-9. PubMed ID: 17470695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
    Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
    Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.
    Paulussen A; Matthijs G; Gewillig M; Verhasselt P; Cohen N; Aerssens J
    Genet Test; 2003; 7(1):57-61. PubMed ID: 12820704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
    Kapplinger JD; Tester DJ; Salisbury BA; Carr JL; Harris-Kerr C; Pollevick GD; Wilde AA; Ackerman MJ
    Heart Rhythm; 2009 Sep; 6(9):1297-303. PubMed ID: 19716085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification in the long-QT syndrome.
    Priori SG; Schwartz PJ; Napolitano C; Bloise R; Ronchetti E; Grillo M; Vicentini A; Spazzolini C; Nastoli J; Bottelli G; Folli R; Cappelletti D
    N Engl J Med; 2003 May; 348(19):1866-74. PubMed ID: 12736279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac sodium channel dysfunction in sudden infant death syndrome.
    Wang DW; Desai RR; Crotti L; Arnestad M; Insolia R; Pedrazzini M; Ferrandi C; Vege A; Rognum T; Schwartz PJ; George AL
    Circulation; 2007 Jan; 115(3):368-76. PubMed ID: 17210841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.
    Moss AJ; Zareba W; Kaufman ES; Gartman E; Peterson DR; Benhorin J; Towbin JA; Keating MT; Priori SG; Schwartz PJ; Vincent GM; Robinson JL; Andrews ML; Feng C; Hall WJ; Medina A; Zhang L; Wang Z
    Circulation; 2002 Feb; 105(7):794-9. PubMed ID: 11854117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?
    Benhorin J; Taub R; Goldmit M; Kerem B; Kass RS; Windman I; Medina A
    Circulation; 2000 Apr; 101(14):1698-706. PubMed ID: 10758053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.
    Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J
    Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
    Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
    Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
    Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial Fibrillation in Long QT Syndrome by Genotype.
    Platonov PG; McNitt S; Polonsky B; Rosero SZ; Zareba W
    Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007213. PubMed ID: 31610692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.
    Hu D; Viskin S; Oliva A; Cordeiro JM; Guerchicoff A; Pollevick GD; Antzelevitch C
    J Electrocardiol; 2007; 40(6 Suppl):S26-9. PubMed ID: 17993325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study.
    Lehtinen AB; Daniel KR; Shah SA; Nelson MR; Ziegler JT; Freedman BI; Carr JJ; Herrington DM; Langefeld CD; Bowden DW
    Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):72-9. PubMed ID: 19149796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.
    Ueda K; Valdivia C; Medeiros-Domingo A; Tester DJ; Vatta M; Farrugia G; Ackerman MJ; Makielski JC
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9355-60. PubMed ID: 18591664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long QT syndrome: a Korean single center study.
    Lee YS; Kwon BS; Kim GB; Oh SI; Bae EJ; Park SS; Noh CI
    J Korean Med Sci; 2013 Oct; 28(10):1454-60. PubMed ID: 24133349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.